• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用病例对照法对卡介苗接种预防结核病的效果进行回顾性评估。

Retrospective assessment of the effectiveness of BCG vaccination against tuberculosis using the case-control method.

作者信息

Smith P G

出版信息

Tubercle. 1982 Mar;63(1):23-35. doi: 10.1016/s0041-3879(82)80006-8.

DOI:10.1016/s0041-3879(82)80006-8
PMID:7080211
Abstract

It is proposed that case-control studies might be used to assess the effect on the incidence of tuberculosis of the mass BCG vaccination campaigns that were conducted in many countries in Africa and Asia from the 1950s onwards. The cost of such studies would be relatively small and they could be completed within a year or two. The results would assist countries in planning their future strategies for tuberculosis control and information on the variation in the protective effect of BCG in a number of different areas in less developed countries may give clues to the reasons for such variation. It is suggested that case-control studies should be designed to include about 200 cases and 3 or 4 times as many controls. The cases should be selected for age such that at the time of the mass vaccination campaign they will have been in an age group in which 20% or less were tuberculin positive. The same approach may be used to assess the effectiveness of giving BCG at birth, provided that this policy has been adopted for some years, coverage has been good (about 50% to 80%) and there are reasonable facilities for diagnosing tuberculosis in children.

摘要

有人提议,可以利用病例对照研究来评估20世纪50年代起在非洲和亚洲许多国家开展的大规模卡介苗接种运动对结核病发病率的影响。此类研究成本相对较小,可在一两年内完成。研究结果将有助于各国规划未来的结核病控制策略,而关于卡介苗在欠发达国家一些不同地区保护效果差异的信息,可能为这种差异的原因提供线索。建议病例对照研究应设计为纳入约200例病例以及3至4倍数量的对照。病例应按年龄进行选择,以便在大规模接种运动时,他们处于结核菌素阳性率为20%或更低的年龄组。如果在出生时接种卡介苗的政策已实施数年、覆盖率良好(约50%至80%)且有合理的儿童结核病诊断设施,同样的方法可用于评估出生时接种卡介苗的效果。

相似文献

1
Retrospective assessment of the effectiveness of BCG vaccination against tuberculosis using the case-control method.采用病例对照法对卡介苗接种预防结核病的效果进行回顾性评估。
Tubercle. 1982 Mar;63(1):23-35. doi: 10.1016/s0041-3879(82)80006-8.
2
Research on BCG vaccination.卡介苗接种研究。
Adv Tuberc Res. 1984;21:79-106.
3
The effect of bacille Calmette-Guérin vaccination at birth on tuberculin skin test reactivity in Ugandan children.出生时接种卡介苗对乌干达儿童结核菌素皮肤试验反应性的影响。
Int J Tuberc Lung Dis. 1999 Oct;3(10):891-5.
4
The effectiveness of BCG vaccination of the newborn against childhood tuberculosis in Bangkok.曼谷新生儿接种卡介苗预防儿童结核病的效果。
Bull World Health Organ. 1986;64(2):247-58.
5
The protective effect of BCG vaccination of the newborn against childhood tuberculosis in an African community.新生儿接种卡介苗对非洲某社区儿童结核病的保护作用。
Tubercle. 1986 Dec;67(4):269-81. doi: 10.1016/0041-3879(86)90016-4.
6
Evaluation of the effectiveness of BCG vaccination using the case-control method in Buenos Aires, Argentina.在阿根廷布宜诺斯艾利斯使用病例对照法评估卡介苗接种的有效性。
Int J Epidemiol. 1988 Sep;17(3):629-34. doi: 10.1093/ije/17.3.629.
7
Does BCG vaccination protect the newborn and young infants?卡介苗接种能保护新生儿和幼儿吗?
Bull World Health Organ. 1980;58(1):37-41.
8
[Evaluation of the protective effect of BCG vaccination against infiltrative pulmonary tuberculosis in the young adult].[卡介苗接种对青年成人浸润性肺结核的保护作用评估]
Zhonghua Jie He He Hu Xi Za Zhi. 1991 Oct;14(5):295-7, 320.
9
[BCG at birth: a discussion of its convenience at the present time].[出生时接种卡介苗:当前关于其便利性的讨论]
An Esp Pediatr. 1984 May;20(8):751-5.
10
Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial.卡介苗复种对无结核菌素皮试史学龄儿童结核病的有效性和成本效益(BCG-REVAC 试验):一项整群随机试验。
Lancet Infect Dis. 2012 Apr;12(4):300-6. doi: 10.1016/S1473-3099(11)70285-7. Epub 2011 Nov 7.

引用本文的文献

1
End-point definition and trial design to advance tuberculosis vaccine development.终点定义和试验设计推进结核病疫苗研发。
Eur Respir Rev. 2022 Jun 7;31(164). doi: 10.1183/16000617.0044-2022. Print 2022 Jun 30.
2
Challenges in estimating influenza vaccine effectiveness.估算流感疫苗有效性的挑战。
Expert Rev Vaccines. 2019 Jun;18(6):615-628. doi: 10.1080/14760584.2019.1622419. Epub 2019 May 31.
3
Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls.病例对照疫苗效果研究:病例与对照的准备、设计及招募
Vaccine. 2017 Jun 5;35(25):3295-3302. doi: 10.1016/j.vaccine.2017.04.037. Epub 2017 Apr 22.
4
Effectiveness of the First Dose of BCG against Tuberculosis among HIV-Infected, Predominantly Immunodeficient Children.首剂卡介苗对HIV感染为主的免疫缺陷儿童结核病的有效性。
Biomed Res Int. 2015;2015:275029. doi: 10.1155/2015/275029. Epub 2015 Jun 29.
5
History of BCG Vaccine.卡介苗疫苗的历史。
Maedica (Bucur). 2013 Mar;8(1):53-8.
6
Protective effect of BCG among children vaccinated under universal immunization programme.卡介苗在扩大免疫规划下接种儿童中的保护作用。
Indian J Pediatr. 2004 Dec;71(12):1069-74. doi: 10.1007/BF02829816.
7
Does B.C.G. vaccination prevent or postpone the occurrence of tuberculous meningitis?卡介苗接种能否预防或推迟结核性脑膜炎的发生?
Indian J Pediatr. 1996 Sep-Oct;63(5):659-64. doi: 10.1007/BF02730815.
8
Protective efficacy of BCG vaccine against leprosy in southern Malaŵi.卡介苗在马拉维南部对麻风病的保护效力
Epidemiol Infect. 1993 Aug;111(1):21-5. doi: 10.1017/s0950268800056636.
9
Tuberculin response two years after BCG vaccination at birth.出生时接种卡介苗两年后的结核菌素反应。
Arch Dis Child. 1984 Jul;59(7):614-9. doi: 10.1136/adc.59.7.614.
10
A case-control study to evaluate the effectiveness of mass neonatal BCG vaccination among Canadian Indians.一项评估加拿大印第安人群体新生儿卡介苗大规模接种效果的病例对照研究。
Am J Public Health. 1986 Jul;76(7):783-6. doi: 10.2105/ajph.76.7.783.